Breaking: Key FDA Panel Backs Pfizer COVID Vaccine for Children Ages 5-11

A Food and Drug Administration panel voted on Tuesday to approve use of the Pfizer-BioNTech coronavirus vaccine for children ages 5-11.

The advisory panel, known as the Vaccines and Related Biological Products Advisory Committee, gave its approval to administer the Pfizer vaccine to children in two doses spaced three weeks apart. Children will receive one-third of the dosage given to people over the age of 12.

Members of the committee debated whether children under the age of 12 require a coronavirus vaccine, or whether to recommend it only for those at higher risk of complications from COVID-19. Ultimately, 17 committee members voted in favor of broad authorization, while one member abstained.

Key FDA Panel Backs Pfizer COVID Vaccine for Children Ages 5-11 The advisory panel gave its approval to administer the Pfizer vaccine to children in two doses spaced three weeks ... READ MORE ADVERTISEMENT Follow Us & Share 19 West 44th Street, Suite 1701, New York, NY, 10036, USA Your Preferences | Unsubscribe | Privacy View this e-mail in your browser.